Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction

American Heart Journal

Volumn 145, Issue 5, 2003, Pages 855-861

  Poloñski, Lech ^a   Ga̧sior, Mariusz ^a   Wasilewski, Jarosław ^a   Wilczek, Krzysztof ^a   Wnȩk, Andrzej ^a   Adamowicz Czoch, Elzbieta ^a   Sikora, Jacek ^a   Lekston, Andrzej ^a   Zȩbik, Tadeusz ^a   Gierlotka, Marek ^a   Wojnar, Rafał ^a   Szkodziñski, Janusz ^a   Kondys, Marek ^a   Szyguła Jurkiewicz, Bozena ^a   Wołk, Robert ^b   Zembala, Marian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; DISEASE ASSOCIATION; EMERGENCY TREATMENT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; INJECTION SITE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; SAFETY; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038403945     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)94823-4     Document Type: Article

References (35)

1. O'Neill WW, Weintraub R, Grines CL, et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation 1992;86:1710-7.
2. The CORAMI Study Group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am J Cardiol 1994;74:172-6.
3. Gibson CM, Cannon CP, Greene RM, et al. Rescue angioplasty in the Thrombolysis In Myocardial Infarction (TIMI) 4 trial. Am J Cardiol 1997;80:21-6.
4. Ross AM, Coyne KS, Reiner JS, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol 1999;34:1954-62.
5. Abbottsmith CW, Topol EJ, George BS, et al. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 1990;16:770-8.
6. Zijstra F, de Boer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
7. Bär F, Vainer J, Stevenhagen J, et al. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. Am Coll Cardiol 2000;36:51-8.
8. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. Circulation 1999;99:2720-32.
9. SPEED Investigators. Triad of abciximab with and without low-dose reteplase for acute myocardial infarction: strategies for patency enhancement in the emergency department (SPEED) group. Circulation 2000;101:2788-94.
10. The GUSTO Angiographic Substudy Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
11. Ellis SG, Ribeiro-daSilva E, Heyndrickx G, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994;90:2280-2.
12. Belenkie I, Traboulsi M, Hall CA, et al. Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: a tenable hypothesis. Can J Cardiol 1992;8:357-62.
13. McKendall GR, Forman S, Sopko G, et al. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995;76:1108-11.
14. Ellis SG, Van de Werf F, Ribeiro-daSilva E, et al. Present status of rescue angioplasty: current polarization of opinion and randomized trials. J Am Coll Cardiol 1992;19:681-6.
15. Liem AL, van'T Hof AWJ, Hoorntje JCA, et al. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1998;32:629-33.
16. Zahn R, Schiele R, Schneider S, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. J Am Coll Cardiol 2000;36:2064-71.
17. Leiboff RH, Katz RJ, Wasserman AD, et al. A randomized angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol 1984;53:404-7.
18. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-85.
19. Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction: the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb). New Engl J Med 1997;336:1621-8.
20. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
21. Moosvi AR, Khaja F, Villanueva L, et al. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-14.
22. Stone GW. Primary PTCA in high risk patients with acute myocardial infarction. J Invasive Cardiol 1995;7:12-21F.
23. Cragg DR, Friedman HZ, Bonema JD, et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991;115:173-7.
24. Lee L, Erbel R, Brown TM, et al. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 1991;17:599-603.
25. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarctian complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991;18:1077-84.
26. Zahn R, Schuster S, Gottwik M, et al. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Circulation 1998;82:259-64.
27. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998;31:1240-5.
28. Rogers WJ, Baim DS, Gore JM, et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial. Circulation 1990;81:1457-76.
29. Ross AM, Lundergan CF, Rohrbeck SC, et al. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in large thrombolysis trial. J Am Coll Cardiol 1998;31:1511-7.
30. Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-8.
31. Simoons ML, Col J, Betriu A, et al. Thrombolysis with tissue plasminogen activator on acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;1:197-203.
32. Waller BF, Rothbaum DA, Pinkerton CA, et al. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator) mechanical (percutaneous transluminal coronary angioplasty) or cambined types of reperfusion therapy. J Am Coll Cardiol 1987;9:785-801.
33. Pavlides GS, Schreiber TL, Gangadharan V, et al. Safety and efficiency of urokinase during elective coronary angioplasty. Am Heart J 1991;121:731-7.
34. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990;322:33-42.
35. Brodie BR, Stuckey TD, Hansen C, et al. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000;85:13-8.